Traws Pharma, Inc. (TRAW) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Traws Pharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.757 Incorporated's second quarter 2025 financial results and business update call. 00:00:04.757 -- 00:00:07.761 At this time, all participants are in listening mode. 00:00:07.761 -- 00:00:11.365 Following management's prepared remarks, we'll hold a question and answer session. 00:00:11.365 -- 00:00:16.832 To ask a question at that time, please press star followed by one on your touchtone phone. 00:00:16.832 -- 00:00:20.497 If anyone has difficulty hearing the conference, please press star zero for operator 00:00:20.497 -- 00:00:22.079 assistance. 00:00:22.079 -- 00:00:26.762 As a reminder, this call is being recorded today, August 14th, 2025. 00:00:27.284 -- 00:00:32.327 At this time, I'd like to turn the call over to John Frentz of LifeSci Advisors. 00:00:32.810 -- 00:00:37.456 Thank you, Operator, and welcome everyone to TRAS Pharma's second quarter 2025 financial 00:00:37.456 -- 00:00:40.479 results and business update conference call. 00:00:40.479 -- 00:00:44.604 This morning, TRAS issued a press release reporting its second quarter 2025 financial 00:00:44.604 -- 00:00:48.648 results and provided a business update. If you have not yet seen this press release, 00:00:48.648 -- 00:00:52.352 it is available in the investor relations section of the company's website. 00:00:52.352 -- 00:00:55.937 Following my introduction, we will hear from TRAS Interim Chief Executive Officer, Dr. 00:00:55.937 -- 00:01:00.729 Ian Dukes, Chief Science Officer, Dr. David Pauza, Chief Medical Officer, Dr. 00:01:00.729 -- 00:01:05.196 Robert Redfield, and Interim Chief Financial Officer, Charles Parker. 00:01:05.196 -- 00:01:08.941 Before we begin, I'd like to remind everyone that statements made during this conference 00:01:08.941 -- 00:01:12.726 call will...